Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-05-10 12:40 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners L.P. | 5,175,500 5.2% | 5,175,500 (New Position) | View |
| 2022-05-04 11:25 am Purchase | 13G | ELIEM THERAPEUTICS INC ELYM | BML Investment Partners L.P. | 1,739,378 6.5% | 1,739,378 (New Position) | View |
| 2022-05-04 11:00 am Purchase | 13G | Forte Biosciences Inc. FBRX | BML Investment Partners L.P. | 888,757 6% | 888,757 (New Position) | View |
| 2022-05-02 4:33 pm Purchase | 13G | RETRACTABLE TECHNOLOGIES INC RVP | BML Investment Partners L.P. | 3,737,500 11.3% | 929,500 (+33.10%) | View |
| 2022-04-25 11:59 am Purchase | 13G | Enliven Therapeutics Inc. ELVN | BML Investment Partners L.P. | 3,180,000 12.1% | 1,547,667 (+94.81%) | View |
| 2022-04-14 10:13 am Purchase | 13G | Enliven Therapeutics Inc. ELVN | BML Investment Partners L.P. | 1,632,333 6.2% | 1,632,333 (New Position) | View |
| 2022-04-13 4:11 pm Purchase | 13G | Disc Medicine Inc. IRON | BML Investment Partners L.P. | 5,270,000 12.2% | 2,940,301 (+126.21%) | View |
| 2022-03-10 2:01 pm Unchanged | 13G | Disc Medicine Inc. IRON | BML Investment Partners L.P. | 2,329,699 5.4% | 0 (Unchanged) | View |
| 2022-03-10 1:16 pm Purchase | 13G | Disc Medicine Inc. IRON | BML Investment Partners L.P. | 2,329,699 5.4% | 2,329,699 (New Position) | View |
| 2022-03-03 1:30 pm Purchase | 13G | ASTROTECH CORP COM PAR $ ASTC | BML Investment Partners L.P. | 2,587,316 5.2% | 2,587,316 (New Position) | View |
| 2022-02-17 8:27 pm Purchase | 13G | METACRINE INC MTCR | BML Investment Partners L.P. | 1,600,000 5.9% | 1,600,000 (New Position) | View |
| 2022-01-28 3:36 pm Unchanged | 13G | ODONATE INC ODTC | BML Investment Partners L.P. | 2,849,657 7.4% | 0 (Unchanged) | View |
| 2022-01-28 3:29 pm Purchase | 13G | ODONATE INC ODTC | BML Investment Partners L.P. | 2,849,657 7.4% | 2,849,657 (New Position) | View |
| 2022-01-27 3:53 pm Purchase | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | BML Investment Partners L.P. | 761,855 5.3% | 761,855 (New Position) | View |
| 2022-01-27 2:58 pm Sale | 13G | TILLYS INC TLYS | BML Investment Partners L.P. | 737,500 3.1% | -612,500 (-45.37%) | View |
| 2022-01-27 2:51 pm Sale | 13G | TALPHERA, INC. TLPH | BML Investment Partners L.P. | 0 0% | -5,956,000 (Position Closed) | View |
| 2022-01-27 2:46 pm Sale | 13G | RICHARDSON ELECTRONICS LTD. RELL | BML Investment Partners L.P. | 710,000 6.2% | -359,186 (-33.59%) | View |
| 2022-01-27 2:27 pm Purchase | 13G | RETRACTABLE TECHNOLOGIES INC RVP | BML Investment Partners L.P. | 2,808,000 8.3% | 823,000 (+41.46%) | View |
| 2022-01-27 2:15 pm Purchase | 13G | LUB LIQUIDATING TRUST LUB | BML Investment Partners L.P. | 1,833,268 5.9% | 251,033 (+15.87%) | View |
| 2021-07-22 10:17 am Purchase | 13G | LUB LIQUIDATING TRUST LUB | BML Investment Partners L.P. | 1,582,235 5.1% | 1,582,235 (New Position) | View |